GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dian Diagnostics Group Co Ltd (SZSE:300244) » Definitions » Cash, Cash Equivalents, Marketable Securities

Dian Diagnostics Group Co (SZSE:300244) Cash, Cash Equivalents, Marketable Securities : ¥2,682 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Dian Diagnostics Group Co Cash, Cash Equivalents, Marketable Securities?

Dian Diagnostics Group Co's quarterly cash, cash equivalents, marketable securities increased from Sep. 2023 (¥2,791.75 Mil) to Dec. 2023 (¥3,391.64 Mil) but then stayed the same from Dec. 2023 (¥3,391.64 Mil) to Mar. 2024 (¥2,682.31 Mil).

Dian Diagnostics Group Co's annual cash, cash equivalents, marketable securities increased from Dec. 2021 (¥2,615.93 Mil) to Dec. 2022 (¥4,650.13 Mil) but then declined from Dec. 2022 (¥4,650.13 Mil) to Dec. 2023 (¥3,391.64 Mil).


Dian Diagnostics Group Co Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Dian Diagnostics Group Co's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dian Diagnostics Group Co Cash, Cash Equivalents, Marketable Securities Chart

Dian Diagnostics Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,600.41 2,053.30 2,615.93 4,650.13 3,391.64

Dian Diagnostics Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,309.33 3,539.76 2,791.75 3,391.64 2,682.31

Dian Diagnostics Group Co Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Dian Diagnostics Group Co  (SZSE:300244) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Dian Diagnostics Group Co Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Dian Diagnostics Group Co's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Dian Diagnostics Group Co (SZSE:300244) Business Description

Traded in Other Exchanges
N/A
Address
No. 329, Jinpeng Street, 5th Floor, Building 2, Xihu District, Zhejiang, Hangzhou, CHN, 310030
Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.
Executives
Chen Hai Bin Director
Chen Shi Shi Supervisors
Guo San Hui Executives
Yao Shu Lie Executives
Xu Min Director
Wang Yan Xiao Directors, executives
Chen Zuo Xiu Directors, executives
Hu Yong Director
Hu Miao Shen Executives
Chen Xue Dong Director
Jiang Tang Directors, executives
Tao Jun Securities Affairs Representative
Wu Zheng Xin Executives
Cheng Xiu Li Supervisors

Dian Diagnostics Group Co (SZSE:300244) Headlines

No Headlines